A detailed history of Parkside Investments, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Parkside Investments, LLC holds 10,635 shares of AMRN stock, worth $4,679. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,635
Previous 10,635 -0.0%
Holding current value
$4,679
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$0.63 - $1.07 $6,700 - $11,379
10,635 New
10,635 $7,000
Q2 2022

Jul 13, 2022

SELL
$1.13 - $3.69 $2,143 - $6,999
-1,897 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$2.85 - $3.73 $5,406 - $7,075
1,897 New
1,897 $6,000
Q1 2021

Apr 14, 2021

SELL
$5.03 - $8.8 $57,251 - $100,161
-11,382 Closed
0 $0
Q4 2020

Jan 13, 2021

SELL
$4.04 - $5.31 $1,555 - $2,044
-385 Reduced 3.27%
11,382 $55,000
Q1 2020

Apr 21, 2020

BUY
$4.0 - $21.53 $47,068 - $253,343
11,767 New
11,767 $47,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Parkside Investments, LLC Portfolio

Follow Parkside Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Investments, LLC with notifications on news.